Finance Inquirer
No Result
View All Result
Thursday, November 5, 2026
  • Login
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market
Subscribe
Finance Inquirer
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market
No Result
View All Result
Finance Inquirer
No Result
View All Result
Home Stock Market

Dow Jones Gains As Inflation Explodes; Tesla Stock Charges Higher; Covid Test Stock Plunges

Tom Hagler by Tom Hagler
13.01.2022
in Stock Market
Dow Jones Gains As Inflation Explodes; Tesla Stock Charges Higher; Covid Test Stock Plunges
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

The Dow Jones Industrial Average moved higher even as inflation hit its highest level in 40 years. Tesla (TSLA) charged higher.

X

Covid testing stock Quest Diagnostics (DGX) plunged on guidance. Microsoft (MSFT) and Salesforce.com (CRM) were among the top blue chips.

Meanwhile a number of stocks were trying to break out. Phillips Edison (PECO), Houlihan Lokey (HLI) and Cirrus Logic (CRUS) all tested buy points.

The U.S. consumer price index exploded 7% in December on a year-over-year basis, the highest rate since 1982. The core price index, which excludes food and energy costs, soared 5.5% in December from a year earlier. That was the fastest pace since 1991.

The 10-year Treasury bond yield ended the day down slightly at 1.73%. Nevertheless, it closed near highs for the day.

Nasdaq Gains As Growth Stocks Excel

The Nasdaq closed the day up 0.2%, well off session highs. Applied Materials (AMAT) was the top performer, turning in a gain of 4.7%.

The S&P 500 fared best out of the major indexes, rising 0.3% despite also trimming gains. Coterra Energy (CTRA) was the best stock here, closing up 6.1%.

U.S. Stock Market Today Overview

Index Symbol Price Gain/Loss % Change
Dow Jones (0DJIA) 36291.50 +39.48 +0.11
S&P 500 (0S&P5) 4726.43 +13.36 +0.28
Nasdaq (0NDQC ) 15188.39 +34.94 +0.23
Russell 2000 (IWM) 216.06 -1.55 -0.71
IBD 50 (FFTY) 42.67 +0.41 +0.97
Last Update: 4:12 PM ET 1/12/2022

The S&P 500 sectors ended the day nearly all positive. Materials, consumer discretionary and technology fared best. Health care was the only laggard.

Small caps fought back from lows, with the Russell 2000 closing down 0.7%.

However growth stocks managed to give the bears a black eye, with the Innovator IBD 50 ETF (FFTY), a bellwether for growth stocks, up 1%.

Microsoft Stock, Salesforce.com Lead Dow Jones

The Dow Jones Industrial Average lagged most out of the major indexes. It still closed with a modest gain of 0.1%, though.

Microsoft was one of the top performers on the Dow Jones today. It closed up 1.1%. The IBD Leaderboard stock has fallen under its 50-day moving average as it forms a flat base. It is shooting for a potential entry of 349.77.

But it was Salesforce.com that took top honors on the index after it rose about 1.3%. The stock remains mired below its 200-day line for now.

The clear loser of the day was banking giant Goldman Sachs (GS). It ended the session down 3.2% but is still forming a cup with handle.

Tesla Stock Charges Higher, EV Stocks Mixed

EV leader Tesla closed up 3.9%. This was enough to make it one of the top performers on both the Nasdaq and the S&P 500.

The stock is now trying to reach a new handle entry of 1,208.10. The new handle is deeper than usual due to recent volatile market conditions.

It comes after a breakout past a double-bottom base buy point of 1,202.05 failed.

Tesla stock gave up all its gains and more after clearing a trendline entry last week. But if the positive market action continues, it could soon retake this level.

Shares traded as high as 1,243.49 on Nov. 4. The stock now sits almost 15% below this level. It remains up more than 30% over the past 12 months, however. Tesla is a member of the IBD Leaderboard list of top growth stocks.

Other EV stocks were having mixed luck. Rivian Automotive (RIVN) closed up 3.5%. However Lucid Motors (LCID) paused a rebound as it fell 0.1%.

Covid Testing Stock Flashes Sells Signals

Quest Diagnostics had a torrid session, closing down almost 7%.

The clinical lab stock has been plunging since it reported Covid testing volumes in Q4 declined compared with the prior year. The firm said Wednesday Q4 revenue would fall 9%.

This was enough to put a dampener on the fact it reported preliminary Q4 EPS of $3.33. This was higher than analyst views for $3.07 per share.

The stock flashed multiple sell signals, including a break below its 10-week moving average. Quest also triggered the 7%-8% sell rule. Those who bought the stock following its breakout above a cup base entry of 160.66 should have already sold their shares.

These Stocks Test Buy Points

A trio of stocks managed to move above entries despite the mixed action.

Shopping center REIT Phillips Edison closed near its buy zone after moving past a consolidation pattern entry of 35.07.

The IPO stock saw its relative strength line hit a new high, a bullish sign. Analyst see earnings soaring by 208% in 2022.

Investment banking play Houlihan Lokey closed just below its buy zone after earlier moving above a cup-without-handle entry of 119.99.

Volume was solid here, a good sign. In addition, its RS line almost reached new heights. Big money has been snapping up the stock.

Fabless semiconductor Cirrus Logic climbed past a cup-with-handle buy point of 95.10.

With the market uptrend still currently under pressure, investors should be extra careful when it come to buying stocks.

It is worth keeping a close tab on stocks performing well under these conditions and add them to one’s watchlist.

Please follow Michael Larkin on Twitter at @IBD_MLarkin for more on growth stocks and analysis.

YOU MIGHT ALSO LIKE:

When Will It Be Time To Buy Tesla, Nvidia, Alphabet Again?

MarketSmith: Research, Charts, Data And Coaching All In One Place

These Are The 5 Best Stocks To Buy And Watch Now

The Ultimate Warren Buffett Stock Is Near A Buy Point, But Should You Buy It?

Is Walmart Stock A Buy Right Now? Here’s What Charts, Analysis Show

The post Dow Jones Gains As Inflation Explodes; Tesla Stock Charges Higher; Covid Test Stock Plunges appeared first on Investor’s Business Daily.

  • Trending
  • Comments
  • Latest
P2Pro: profitable changes are coming!

P2Pro: profitable changes are coming!

13.09.2022
Saving and investing the two keys to your future retirement

Saving and investing the two keys to your future retirement

21.06.2022
The Dow Jones slept through the whole trade despite positive data from the labor market. Nasdaq had its best streak of gains this year

The Dow Jones slept through the whole trade despite positive data from the labor market. Nasdaq had its best streak of gains this year

01.09.2022
The ranking of countries in terms of the coverage of children with preschool education has been compiled

The ranking of countries in terms of the coverage of children with preschool education has been compiled

03.11.2022
Take the best photos of your life with the new vivo Y76 5G now available

Take the best photos of your life with the new vivo Y76 5G now available

Complete your Christmas shopping with up to 75% off on devices at vivo’s Big Christmas Sale on Shopee

Complete your Christmas shopping with up to 75% off on devices at vivo’s Big Christmas Sale on Shopee

AirPods 3 vs AirPods 2 – What’s the Difference?

AirPods 3 vs AirPods 2 – What’s the Difference?

Want to be a content creator? Here are 5 valuable tips from today’s top Pinoy online celebrities

Want to be a content creator? Here are 5 valuable tips from today’s top Pinoy online celebrities

European Technical Expands AMC Services Across Dubai Amid Rising Demand

04.11.2026
Occams Advisory Earns 9th Inc. 5000 Honor, Soars to No. 798 in 2025

Occams Advisory Earns 9th Inc. 5000 Honor, Soars to No. 798 in 2025

12.09.2025

A Family debt of €20 million marks a new chapter in Dasha Ozden’s life

04.09.2025

SnapInspect Shares Five Key Factors to Consider When Choosing Property Inspection Software

25.08.2025

Recent News

European Technical Expands AMC Services Across Dubai Amid Rising Demand

04.11.2026
Occams Advisory Earns 9th Inc. 5000 Honor, Soars to No. 798 in 2025

Occams Advisory Earns 9th Inc. 5000 Honor, Soars to No. 798 in 2025

12.09.2025

Categories

  • Business
  • Finance
  • News
  • Stock Market
  • Technology
  • Без рубрики

Site Navigation

  • Home
  • Contact Us
Finance Inquirer

We offer multimedia features, easy channel navigation, strong social media presence and numerous engagement platforms that allow the readers to experience content anytime, anywhere, always.

No Result
View All Result
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market

© 2021 financeinquirer.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In